Mary Eileen Dolan to Myeloid-Lymphoid Leukemia Protein
This is a "connection" page, showing publications Mary Eileen Dolan has written about Myeloid-Lymphoid Leukemia Protein.
Connection Strength
0.101
-
Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia. Clin Pharmacol Ther. 2008 Dec; 84(6):691-7.
Score: 0.080
-
Mouse models of human AML accurately predict chemotherapy response. Genes Dev. 2009 Apr 01; 23(7):877-89.
Score: 0.021